GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 783 filers reported holding GLAXOSMITHKLINE PLC in Q2 2017. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $2,251,000 | -19.5% | 59,810 | -12.7% | 0.04% | -27.6% |
| Q2 2020 | $2,796,000 | -14.6% | 68,534 | -20.7% | 0.06% | -31.0% |
| Q1 2020 | $3,274,000 | -25.3% | 86,400 | -7.3% | 0.08% | -14.3% |
| Q4 2019 | $4,380,000 | +25.8% | 93,219 | +14.2% | 0.10% | +11.4% |
| Q3 2019 | $3,483,000 | +8.2% | 81,606 | +1.5% | 0.09% | +1.1% |
| Q2 2019 | $3,218,000 | -19.8% | 80,422 | -16.3% | 0.09% | -24.3% |
| Q1 2019 | $4,013,000 | +8.9% | 96,044 | -0.4% | 0.12% | -4.2% |
| Q4 2018 | $3,685,000 | -24.6% | 96,443 | -20.7% | 0.12% | -14.9% |
| Q3 2018 | $4,889,000 | +2.2% | 121,689 | +2.6% | 0.14% | -4.1% |
| Q2 2018 | $4,783,000 | +2.1% | 118,655 | -1.0% | 0.15% | -2.6% |
| Q1 2018 | $4,683,000 | +16.9% | 119,850 | +6.1% | 0.15% | +18.0% |
| Q4 2017 | $4,007,000 | -17.3% | 112,955 | -5.4% | 0.13% | -26.0% |
| Q3 2017 | $4,848,000 | +6.7% | 119,400 | +13.3% | 0.17% | -1.1% |
| Q2 2017 | $4,545,000 | +13.5% | 105,406 | +11.0% | 0.18% | +6.1% |
| Q1 2017 | $4,004,000 | +11.5% | 94,975 | +1.8% | 0.16% | +0.6% |
| Q4 2016 | $3,592,000 | -26.5% | 93,286 | -17.7% | 0.16% | -30.8% |
| Q3 2016 | $4,888,000 | +23.5% | 113,340 | +24.1% | 0.24% | +12.9% |
| Q2 2016 | $3,958,000 | +107.9% | 91,321 | +94.5% | 0.21% | +94.4% |
| Q1 2016 | $1,904,000 | +52.3% | 46,950 | +51.5% | 0.11% | +47.9% |
| Q4 2015 | $1,250,000 | +46.2% | 30,986 | +39.4% | 0.07% | +37.7% |
| Q3 2015 | $855,000 | +35.1% | 22,224 | +46.3% | 0.05% | +43.2% |
| Q2 2015 | $633,000 | +15.5% | 15,189 | +28.0% | 0.04% | +12.1% |
| Q1 2015 | $548,000 | +36.7% | 11,867 | +26.5% | 0.03% | +37.5% |
| Q4 2014 | $401,000 | +45.3% | 9,379 | +56.2% | 0.02% | +33.3% |
| Q3 2014 | $276,000 | +97.1% | 6,006 | +129.8% | 0.02% | +80.0% |
| Q1 2014 | $140,000 | -50.0% | 2,614 | -50.1% | 0.01% | -54.5% |
| Q4 2013 | $280,000 | -20.9% | 5,242 | -25.7% | 0.02% | -33.3% |
| Q3 2013 | $354,000 | +10.6% | 7,052 | +10.3% | 0.03% | -2.9% |
| Q2 2013 | $320,000 | – | 6,391 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
| Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
| Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
| Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
| P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
| Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
| Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
| Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
| Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
| JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |